• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Thursday, October 31, 2019

    Offline Date

    Thursday, April 30, 2020

    ACPE Expiration Date

    Monday, October 31, 2022

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      This presentation will cover recent updates to breast cancer literature and FDA approvals of drugs used in the treatment of breast cancer. Changes to adjuvant antiHER2 therapy will be discussed as well as new options for treatment of hormone receptor-negative, HER2-negative breast cancer. Potential side effects of drugs and management, if applicable, will be reviewed during this presentation. Future directions for treatment of breast cancer will be highlighted.

      Handouts

      • Slide Document :   ce_9_slides.pdf

      Financial Support By

      joint funding from Advanced Accelerator Applications, a Novartis Company, BMS and Pfizer Alliance, Celgene Corporation, Merck & Co., Inc., and Pfizer
    • Pharmacist

      Recognize the changes in treatment for early stage HER2-positive breast cancer
      Compare efficacy and toxicities of new agents for the treatment of HER2-negative breast cancer
      Describe management of immunotherapy for the treatment of breast cancer

      Nurse

      Compare efficacy and toxicities of new agents for the treatment of HER2-negative breast cancer
      Recognize the changes in treatment for early stage HER2-positive breast cancer
      Describe management of immunotherapy for the treatment of breast cancer
    • Activity Type

      Application

      CE Broker

      20-747610

      Universal Activity Number

      Pharmacist 0798-0000-19-192-H01-P
      Nurse 0798-0000-19-192-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    • Faculty

      Neelam  Patel, PharmD, BCOP
      Clinical Pharmacy Specialist Breast Medical Oncology; The University of Texas MD Anderson Cancer Center

    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).